- Received February 09, 2021
- Accepted March 17, 2021
- Publication June 07, 2021
- Visibility 8 Views
- Downloads 0 Downloads
- DOI 10.18231/j.ijirm.2021.020
-
CrossMark
- Citation
Study of COVID-19 epidemic in India and Andhra Pradesh with comparative global figures
- Author Details:
-
Ramakrishna Rachakonda *
-
Kiranmavi Abburi
-
Sai Ramya Gonuguntla
-
Bhavanarayana Jannela
-
Chakradhar Bolleddu
-
DVC Nagasree
Introduction
Corona virus or COVID -19 virus disease rattled the entire world and still is spreading rapidly in Europe and America. First reported in Wuhan city in China and spread to the entire world causing considerable human morbidity and mortality.[1] The novel Corona virus disease has resulted in sudden increase in cases of viral Pneumonia worldwide with multi organ failure. The virus spreads from asymptomatic and symptomatic individuals with an incubation period of five days. The disease is diagnosed by reverse transcriptase polymerase chain reaction that has a sensitivity of around 67%.[2]
Drugs like Hydroxychloroquine, Ivermectin, Tocilizumab, Remdesivir have been used with insufficient evidence.[3] Glucocorticoids with their anti-inflammatory effect have been found to be very useful and reduced mortality.[4] As per autopsy reports done on patients dying of COVID-19 disease patients with and without comorbidities suffered from extrapulmonary lesions like hepatic, renal, bone marrow involvement with microvascular injury and thrombosis. Lung and cardiovascular involvement are predominant.[5] Autopsy, electron microscopy and molecular biology of the specimen have resulted in better understanding of the pathology of covid disease.[6] There is diffuse alveolar damage, with extensive inflammation with microvascular thrombin, hyaline membranes, endothelial inflammation, hemorrhage and angiogenesis. Vascular lesions are more significant.[7] COVID-19 related Acute Respiratory Distress Syndrome occurred in 8-12 days after the onset and High Flow Nasal Oxygen proved effective in mild to moderate disease.[8] Over production of inflammatory cytokines like IL-6, and Tumor Necrotic Factor alpha lead to systemic inflammation and acute myocardial infarction. Because of the affinity of corona virus to ACE 2 receptors and its effect on rennin angiotensin aldosterone system it can produce myocarditis and can lead to left ventricular dysfunction, myocardial inflammation and pericardial involvement and finally haemodynamic instability.[9] Worldometer statistics reveals that there are a total of 105 million cases in the world and 2.3 million deaths.
The COVID-19 epidemic is seen in 221 countries in the world and World Health Organization declared it as a pandemic. COVID-19 disease is mild to moderate in 80% of cases. Severe disease occurs in 15% and critical illness in 5%. Case fatality rate of 0.5–2.8% with much higher rates (3.7–14.8%) in old age.[10] The virus is transmitted by air and by direct and indirect contact and most frequent way of spread is by droplets.It can cause mild flu like symptoms to overwhelming pneumonia and can cause death.[11]
Several countries including India adopted the principle of containment of disease, contact tracing and isolation of disease clusters. 85% of cases occurred due to human to human transmission and cases occurred because of unprotected exposure. Transmission took place during early part of infection.[12] The COVID-19 disease spread to all the countries in the worldwithin three months of its onset from Wuhan in China and was declared a pandemic by WHO on 11th March 2020. Because of its contagiousness and morbidity and mortality the pandemic has a deep impact on the economy of several developing countries.[13]
Health care workers in China were aware of the infectiousness of disease and more than 85% of them took adequate precautions. Proper training of health care workers regarding protective precautions and adequate rest in between is found to be absolutely essential.[14] Compared to general population health care workers have higher prevalence of COVID-19 positivity.[15] The pandemic entered India by the end of January 2020 and spread rapidly and has its impact socially, economically and culturally.[16] Complete lock down and isolation of cases were implemented in India from March 2020
Materials and Methods
It is an observational study of COVID-19 epidemic in our tertiary care covid hospital. We also studied the statistics of Andhra Pradesh and other Indian states as per the publication of Ministry of health and Family welfare and WHO publications and worldometer corona statistics.
Place of study
NRI Medical College Hospital, Chinnakakani, Guntur District, Andhra Pradesh
Duration of study
March 2020 to January 2021
Study design
Prospective Observational study
Results
Month |
No.of Positives |
No. of deaths |
Until March |
40 |
0 |
April |
1363 |
31 |
May |
1639 |
31 |
June |
11533 |
125 |
July |
126338 |
1162 |
August |
293838 |
2620 |
September |
252580 |
1811 |
October |
135997 |
910 |
November |
39716 |
302 |
December |
14222 |
116 |
January 2021 |
5550 |
45 |
District |
No.of Positives |
No.of deaths |
Percentage |
Anantapur |
67644 |
599 |
0.88% |
Chittoor |
87035 |
847 |
0.97% |
East Godavari |
124260 |
636 |
0.51% |
Guntur |
75504 |
670 |
0.89% |
YSR Kadapa |
55264 |
463 |
0.84% |
Krishna |
48661 |
676 |
1.39% |
Kurnool |
60816 |
488 |
0.80% |
Nellore |
62325 |
506 |
0.81% |
Prakasam |
62175 |
580 |
0.93% |
Srikakulam |
46125 |
347 |
0.75% |
Visakhapatnam |
59763 |
561 |
0.94% |
Vizianagaram |
41133 |
238 |
0.58% |
West Godavari |
94236 |
542 |
0.57% |
State |
No. of COVID cases |
Deaths |
Case fatality rate |
Kerala |
929179 |
3744 |
0.40% |
Maharashtra |
20,26,399 |
51082 |
2.52% |
Karnataka |
939387 |
12217 |
1.30% |
Tamilnadu |
838340 |
12356 |
1.47% |
Delhi |
635096 |
10853 |
1.71% |
West Bengal |
569998 |
10173 |
1.78% |
Uttar Pradesh |
600299 |
8658 |
1.44% |
Andhra pradesh |
887836 |
7153 |
0.80% |
Telangana |
294469 |
1599 |
0.54% |
India |
10815222 |
154956 |
1.47% |
Total No. of Patients Admitted |
Total No. of Deaths |
Mortality Percentage |
10691 |
419 |
3.92% |
Month |
No. of Patients |
Deaths |
Percentage |
April 2020 |
277 |
0 |
0 |
May 2020 |
161 |
0 |
0 |
June 2020 |
515 |
0 |
0 |
July 2020 |
2889 |
66 |
2.28% |
August 2020 |
2595 |
138 |
5.32% |
September 2020 |
2277 |
93 |
4.08% |
October 2020 |
1541 |
51 |
3.31% |
November 2020 |
744 |
34 |
4.57% |
December 2020 |
303 |
28 |
9.24% |
January 2021 |
124 |
7 |
5.64% |
February 2021 |
4 |
2 |
2 |
Total |
10682 |
419 |
3.92% |
Country |
No. of COVID-19 Cases Reported |
No. of Deaths |
Mortality Percentage |
World |
106685660 |
2327308 |
2.18% |
USA |
27.6 Millions |
474933 |
1.74% |
Mexico |
1.9 Million |
165786 |
8.72% |
Brazil |
9,524,640 |
231561 |
3.55% |
UK |
3,945680 |
112465 |
2.85% |
Russia |
3,967281 |
76661 |
1.93% |
India |
10,838, 843 |
155114 |
1.47% |
South Africa |
1476135 |
46290 |
3.13% |
Italy |
2636738 |
91273 |
3.46% |
Discussion
COVID-19 pandemic in Andhra Pradeshhas declined to a considerable extent because of containment, isolation and treatment facilities provided by the Government of Andhra Pradesh. Overall mortality is less than 1% and is less than the national average. Godavari districts of Andhra Pradesh showed maximum number of patients because of dense population and low mortality is probably because of better awareness among population and better treatment options. Chittoor and Guntur districts showed fairly large number of cases possibly because of pilgrim and commercial activity respectively.
Study of different states revealed highest number of cases in Maharashtra with a case fatality rate of 2.52%. Andhra Pradesh has less than 1% case fatality rate. Kerala showed the least case fatality rate of 0.40%
Statistical analysis of COVID-19 in Andhra Pradesh revealed that positive cases were reported from the month of March 2020. The number of cases reached its peak in the month of August 2020 and the decline started. Less than one hundred cases are reported per day at the end of January 2021.
Deaths from COVID-19 disease started from April 2020. Reached its peak in August 2020 and the gradual decline started. East Godavari, West Godavari, Guntur and Chittoor districts reported large number of cases. East Godavari district topped with more than 1,24,000 cases during the pandemic. Surprisingly the death rate in Eastand West Godavari districts is around 0.5%. Overall death rate in the general population in Andhra Pradesh is less than 1%
India is a mosaic country with different states showed different case burden and different case fatality rates. Maharashtra has highest number of cases with case fatality rate of 2.52%. Andhra Pradesh, Telangana and Kerala have a case fatality rate of less than 1%. Highest number of cases in Maharashtra can probably be attributed to large urban slums in cities like Mumbai.
Internationally highest disease burden was seen in United States but case fatality is high in Mexico. European countries have considerably high case fatality rates.
Hospital based study revealed highest number of COVID-19 cases were recorded in the month of July 2020 and highest number of deaths took place in the month of August 2020 in our tertiary care center. Overall mortality among COVID-19 patients in the hospital is 3.92%
Lockdown and isolation measures adopted in India helped to contain the rapid spread of disease. During this period awareness of the disease among the Indian public increased. Death rate among the general population in different districts of Andhra Pradesh on the whole has been less than one percent. COVID-19 hospital statistics revealed nearly 3.92% mortality. This is because many patients had treatment outside before they joined the hospital. Increased use of corticosteroid and anticoagulants decreased mortality among admitted COVID-19 patients.
Summary
We have analyzed the data published by Ministry of Health and family Welfare Government of India, Government of Andhra Pradesh and WHO statistics as well as worldometer statistics. We have studied the hospital statistics of our tertiary care COVID center and analyzed the results.
The statistics revealed highest number of cases are seen in United States of America with case fatality rate of 1.74%.Mexico has highest case fatality rate of 8.5%. Italy has 3.5% and United Kingdom 2.8%.
In India Maharashtra has highest number of COVID-19 casualties with case fatality of 2.52%. Indian national average of case fatality is 1.47%. Andhra Pradesh has a case fatality of 0.80%. In Andhra Pradesh the pandemic of COVID-19 peaked in the months of August and September both in terms of number of cases and deaths.
Hospital based records showed a death rate of 3.92%.
Conclusions
COVID-19 pandemic differed in different countries and different Indian states. The reason probably is the difference in virulence of the organism as well as innate resistance in different populations. Measures of isolation of cases and lockdown measures observed in India decreased the mortality rate. Use of anticoagulants and corticosteroids also contributed to decreased fatality in India
Acknowledgement
None.
Source of Funding
No financial support was received for the work within this manuscript.
Conflict of Interest
The authors declare that they have no conflict of interest.
References
- . COVID-19 Treatment Guidelines Panel. Coronavirus Disease 2019 (COVID-19) Treatment Guidelines. National Institutes of Health. Available from URL:-https://www.covid19treatmentguidelines.nih.gov/. Last accessed 2021 on May 1. . [Google Scholar]
- WJ Wiersinga. Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19) A Review. AMA 2020. [Google Scholar]
- . COVID-19 Treatment Guidelines. Available from URL:-https://www.covid19treatmentguidelines.nih.gov/. Last accessed 2021 on May 1. . [Google Scholar]
- VI Alexaki, H Henneicke. Glucocorticoids in COVID-19. Horm Metab Res 2021. [Google Scholar]
- L Falasca. Post Mortem Findings in Italian Patients with COVID-19 - a Descriptive Full Autopsy Study of cases with and without co-morbidities. J Infect Dis 2020. [Google Scholar]
- F Calabrese, F Pezzuto, F Fortarezza, P Hofman, I Kern, A Panizo. Pulmonary pathology and COVID-19: lessons from autopsy. The experience of European Pulmonary Pathologists. Virchows Arch 2020. [Google Scholar] [Crossref]
- CN Englisch, T Tschernig, F Flockerzi, C Meier, RM Bohle. Lesions in the lungs of fatal corona virus disease Covid-19. Ann Anat 2021. [Google Scholar] [Crossref]
- X Li, X Ma. Acute respiratory failure in COVID-19: is it “typical” ARDS?. Li Ma Crit Care 2020. [Google Scholar]
- R B Azevedo. Practical Approach to Acute Coronary Syndrome in Patients with COVID-19. Intl J Cardiovasc Sci 2020. [Google Scholar]
- AA Balkhair. COVID-19 Pandemic: A New Chapter in the History of Infectious Diseases. Oman Med J 2020. [Google Scholar] [Crossref]
- L Cirrincione, F Plescia, C Ledda, V Rapisarda, D Martorana, RE Moldovan. COVID-19 Pandemic: Prevention and Protection Measures to Be Adopted at the Workplace. Sustainability 2020. [Google Scholar] [Crossref]
- J Bedford, D Enria, J Giesecke, DL Heymann, C Ihekweazu, G Kobinger. COVID-19: towards controlling of a pandemic. Lancet 2020. [Google Scholar] [Crossref]
- SA Lone, A Ahmad. COVID-19 pandemic – an African perspective. Emerg Microbes Infect 2020. [Google Scholar] [Crossref]
- M Zhang. Knowledge, attitude, and practice regarding COVID-19 among healthcare workers in Henan China. J Hospital Infect 2020. [Google Scholar]
- L H Nguyen, D A Drew, A D Joshi, C G Guo, W Ma, R S Mehta. Risk of COVID-19 among frontline healthcare workers and the general community: a prospective cohort study. Lancet Public Health 2020. [Google Scholar]
- A Khandelwal, A Agarwal, A Kumar. An Outbreak of Coronavirus (COVID-19) Epidemic in India: Challenges and Preventions. J Infect Dis Ther 2020. [Google Scholar]